Phase IV, multicenter, randomized, evaluator-blind, comparative study with active treatment to determine the incidence of squamous cell carcinoma and evaluate the long-term safety of the administration of tirbanibulin 10 mg/g ointment and diclofenac sodium 3% gel for the treatment of adult patients with actinic keratosis on the face or scalp.

COMMERCIAL CLINICAL TRIAL